Megumi Shimoyama

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Reactive Oxygen Species

Neuropathic Pain

Emergency Department

Chemotherapy Induced

Top Venues

Chemical biology & drug design

ACS chemical neuroscience

This page only lists publications with an associated author ORCID identifier.

Publications

Kensaku Itoh, Megumi Shimoyama, Peter W Schiller, Satoshi Toyama
Protective effect of a mitochondria-targeting peptide against paclitaxel-induced peripheral neuropathy. Chemical biology & drug design 101 (4) (2022)
Kensaku Itoh, Megumi Shimoyama, Peter W Schiller, Satoshi Toyama
Protective effect of a mitochondria-targeting peptide against paclitaxel-induced peripheral neuropathy. Chemical biology & drug design 101 (4) (2022)
Kensaku Itoh, Megumi Shimoyama, Peter W Schiller, Satoshi Toyama
Protective effect of a mitochondria-targeting peptide against paclitaxel-induced peripheral neuropathy. Chemical biology & drug design 101 (4) (2022)
Kensaku Itoh, Megumi Shimoyama, Peter W Schiller, Satoshi Toyama
Protective effect of a mitochondria-targeting peptide against paclitaxel-induced peripheral neuropathy. Chemical biology & drug design (2022)
Satoshi Toyama, Naohito Shimoyama, Hazel H Szeto, Peter W Schiller, Megumi Shimoyama
Protective Effect of a Mitochondria-Targeted Peptide against the Development of Chemotherapy-Induced Peripheral Neuropathy in Mice. ACS chemical neuroscience 9 (7) (2018)